Fredrikson Represents Bio-Techne in Acquisition of Novus Biologicals

Fredrikson acted as legal counsel to Techne Corporation (NASDAQ:TECH), d/b/a Bio-Techne, a company engaged in the development, manufacture and sale of biotechnology-based products and clinical calibrators and controls, in its acquisition of Novus Biologicals for $60 million. Novus Biologicals is a supplier of antibodies and other reagents for life science research. Fredrikson’s legal team included Alexander Rosenstein, Zachary D. Olson, Thomas F. Manewitz and Lori P. Cobb.